melanoma (Disease)

Synonyms:malignant melanoma, Naevocarcinoma

Id:DOID:1909

Description:A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from melanocytes which are found in skin, the bowel and the eye.

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC CYT001 A375 4h INHBA 10ng per ml.tsv.gz File (Entity type)	A 295 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC KDB006 A375 96H B16 MARK4 Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project
	L1000 LINCS DCIC REP.A015 A375 24H H13 vilazodone 10.0um.tsv.gz File (Entity type)	A 161 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A027 A375 24H F12 DMSO.tsv.gz File (Entity type)	A 281 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC MOAR012 SH4 24H N22 ginkgolide-b 10uM.tsv.gz File (Entity type)	A 89.7 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 XPR046 HS944T.311 96H H23 BRDN0001149424 Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC MOAR001 A375 24H K24 SB-705498 1.11uM.tsv.gz File (Entity type)	A 137 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP009 A375 24H O06 PD-0325901 0.04uM.tsv.gz File (Entity type)	A 136 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR010 MELHO 24H C10 hymecromone 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC KDB005 A375 96H P14 SOX4.tsv.gz File (Entity type)	A 298 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC CYT001 A375 4h INHBA 10ng per ml.tsv.gz

File (Entity type)

A 295 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC KDB006 A375 96H B16 MARK4

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC REP.A015 A375 24H H13 vilazodone 10.0um.tsv.gz

File (Entity type)

A 161 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project

L1000 LINCS DCIC REP.A027 A375 24H F12 DMSO.tsv.gz

File (Entity type)

A 281 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC MOAR012 SH4 24H N22 ginkgolide-b 10uM.tsv.gz

File (Entity type)

A 89.7 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 XPR046 HS944T.311 96H H23 BRDN0001149424

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC MOAR001 A375 24H K24 SB-705498 1.11uM.tsv.gz

File (Entity type)

A 137 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC LJP009 A375 24H O06 PD-0325901 0.04uM.tsv.gz

File (Entity type)

A 136 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR010 MELHO 24H C10 hymecromone 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC KDB005 A375 96H P14 SOX4.tsv.gz

File (Entity type)

A 298 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.